Enrichment of gut-derived metabolites in a Parkinson's disease subtype with REM sleep behavior disorder

Abstract

Recent reports indicate that Parkinson's disease (PD)-like changes in gut microbial signatures develop in idiopathic REM sleep behavior disorder (iRBD), a prodrome of alpha-synucleinopathies. However, <50% of PD cases exhibit RBD at onset, underscoring PD's heterogeneity. Using untargeted metabolomics, plasma samples from PD patients with and without RBD, iRBD subjects, and healthy controls were analyzed to characterize the metabolic differences in PD patients with and without RBD. Metabolomic analysis revealed the enrichment of gut microbial-origin metabolites, such as secondary bile acids and p-cresol sulfate, in PD patients with RBD, while metabolites linked to neuropsychiatric diseases were elevated in PD patients without RBD. Additionally, our prediction that p-cresol sulfate, enriched in the RBD groups with a gut microbial origin, crosses the blood-brain barrier, suggests a potential mechanistic link between gut microbial dysbiosis, iRBD, and PD with RBD. Our study elucidates the heterogeneous nature of PD subtypes.